Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Van Biesen

Showing results (11-20 of 66) with videos related to

Pageof 7
Sort By:
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|September 28, 2000
The role of peritoneal dialysis as the first-line renal replacement modalityW Van Biesen, R Vanholder, N Lameire
Journal of the American Society of Nephrology : JASN|March 17, 2001
What is the renal replacement method of first choice for intensive care patients?R Vanholder, W Van Biesen, N Lameire
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|July 27, 2000
The role of peritoneal dialysis as first modality in an integrative approach to patients with end-stage renal diseaseN Lameire, W Van Biesen, R Vanholder
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 25, 2001
An integrated approach to end-stage renal diseaseW Van Biesen, S Davies, N Lameire
Acta Clinica Belgica|March 21, 2008
Internal medicine, renal anaemia, and erythropoiesis-stimulating agents (ESAS)N Veys, W Van Biesen, N Lameire
Advances in Renal Replacement Therapy|August 1, 1998
Recent developments in osmotic agents for peritoneal dialysisW Van Biesen, R Vanholder, N Lameire
Kidney International|July 1, 1993
Contributing factors to the inhibition of phagocytosis in hemodialyzed patientsR Vanholder, W Van Biesen, S Ringoir
Nephron. Clinical Practice|January 4, 2005
To pee or not to pee: no more the question in ARF?R Vanholder, W Van Biesen, N Lameire
Nephron. Clinical Practice|December 4, 2009
Advantages of new hemodialysis membranes and equipmentR Vanholder, G Glorieux, W Van Biesen
Journal of the American Society of Nephrology : JASN|July 11, 2001
End-stage renal disease treatment: a European perspectiveW Van Biesen, M Wiedemann, N Lameire
Pageof 7

Showing results (11-20 of 66) with videos related to

Sort By:
Pageof 7
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|September 28, 2000
The role of peritoneal dialysis as the first-line renal replacement modalityW Van Biesen, R Vanholder, N Lameire
Journal of the American Society of Nephrology : JASN|March 17, 2001
What is the renal replacement method of first choice for intensive care patients?R Vanholder, W Van Biesen, N Lameire
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|July 27, 2000
The role of peritoneal dialysis as first modality in an integrative approach to patients with end-stage renal diseaseN Lameire, W Van Biesen, R Vanholder
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 25, 2001
An integrated approach to end-stage renal diseaseW Van Biesen, S Davies, N Lameire
Acta Clinica Belgica|March 21, 2008
Internal medicine, renal anaemia, and erythropoiesis-stimulating agents (ESAS)N Veys, W Van Biesen, N Lameire
Advances in Renal Replacement Therapy|August 1, 1998
Recent developments in osmotic agents for peritoneal dialysisW Van Biesen, R Vanholder, N Lameire
Kidney International|July 1, 1993
Contributing factors to the inhibition of phagocytosis in hemodialyzed patientsR Vanholder, W Van Biesen, S Ringoir
Nephron. Clinical Practice|January 4, 2005
To pee or not to pee: no more the question in ARF?R Vanholder, W Van Biesen, N Lameire
Nephron. Clinical Practice|December 4, 2009
Advantages of new hemodialysis membranes and equipmentR Vanholder, G Glorieux, W Van Biesen
Journal of the American Society of Nephrology : JASN|July 11, 2001
End-stage renal disease treatment: a European perspectiveW Van Biesen, M Wiedemann, N Lameire
Pageof 7